• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四联疗法联合益生菌对相关性消化性溃疡的影响。

Effects of Quadruple Therapy Combined with Probiotics on -Related Peptic Ulcer.

机构信息

Department of Gastroenterology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China 210019.

出版信息

Comput Math Methods Med. 2022 Oct 11;2022:1221190. doi: 10.1155/2022/1221190. eCollection 2022.

DOI:10.1155/2022/1221190
PMID:36267315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9578884/
Abstract

The present study was designed to observe the effect of quadruple therapy combined with probiotics on -related peptic ulcer. The patients in the control group ( = 90) were given regular quadruple therapy including proton pump inhibitor ilaprazole enteric-coated tablet + two antibiotics amoxicillin dispersible tablet and metronidazole tablet + colloidal bismuth pectin capsule for 2 weeks. Patients in the study group ( = 90) were given abovementioned quadruple therapy combined with probiotics live combined , , and Capsules, oral for 2 weeks. Then Hp clearance rate, recurrence rate, levels of gastrointestinal hormone makers, and advance reactions between two groups were compared. At the 2nd week after the treatment, the clearance rate in the study group (87.79%) was significantly higher than the control group (78.89%), and the total recurrence rate in the study group (6.67%) was significantly lower than the control group (13.33%) ( < 0.05). Serum gastrin and motilin expression were lower, and somatostatin expressions was significantly higher than those in the control group ( < 0.05). There was no significant difference in the total incidence of adverse reactions between the two groups ( > 0.05). In summary, quadruple therapy combined with probiotics in the treatment of -related peptic ulcer can improve the clearance rate, reduce the recurrence rate, and is beneficial to improving the level of gastrointestinal hormones, with certain safety.

摘要

本研究旨在观察四联疗法联合益生菌对相关消化性溃疡的治疗效果。对照组(n=90)给予常规四联疗法,包括质子泵抑制剂艾普拉唑肠溶片+两种抗生素阿莫西林分散片和甲硝唑片+胶体果胶铋胶囊,疗程 2 周。观察组(n=90)在上述四联疗法的基础上加用益生菌双歧杆菌三联活菌肠溶胶囊、,口服,疗程 2 周。比较两组 Hp 清除率、复发率、胃肠激素标志物水平及不良反应发生情况。治疗第 2 周末,观察组 Hp 清除率(87.79%)显著高于对照组(78.89%),观察组总复发率(6.67%)显著低于对照组(13.33%)(<0.05)。观察组血清胃泌素和胃动素表达降低,生长抑素表达升高,与对照组比较差异有统计学意义(<0.05)。两组不良反应总发生率比较差异无统计学意义(>0.05)。综上所述,四联疗法联合益生菌治疗相关消化性溃疡可提高 Hp 清除率,降低复发率,有利于改善胃肠激素水平,且具有一定安全性。

相似文献

1
Effects of Quadruple Therapy Combined with Probiotics on -Related Peptic Ulcer.四联疗法联合益生菌对相关性消化性溃疡的影响。
Comput Math Methods Med. 2022 Oct 11;2022:1221190. doi: 10.1155/2022/1221190. eCollection 2022.
2
Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.胶体果胶铋:治疗幽门螺杆菌阳性十二指肠溃疡的枸橼酸铋钾替代药物
Helicobacter. 1999 Jun;4(2):128-34. doi: 10.1046/j.1523-5378.1999.98281.x.
3
Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial.基于安妥沙星的10天和14天疗法与基于克拉霉素的14天铋剂四联疗法根除幽门螺杆菌的比较:一项随机试验
Clin Res Hepatol Gastroenterol. 2023 Jan;47(1):102052. doi: 10.1016/j.clinre.2022.102052. Epub 2022 Nov 15.
4
Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.幽门螺杆菌根除的挽救治疗:铋剂四联疗法中阿莫西林或四环素的随机非劣效性试验
Am J Gastroenterol. 2016 Dec;111(12):1736-1742. doi: 10.1038/ajg.2016.443. Epub 2016 Sep 27.
5
High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.含铋剂的14天高剂量质子泵抑制剂联合益生菌根除幽门螺杆菌的高效四联疗法:一项双盲随机安慰剂对照研究
Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2859-2864. doi: 10.31557/APJCP.2019.20.9.2859.
6
First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.黎巴嫩幽门螺杆菌的一线治疗:含铋四联疗法与 14 天序贯疗法的比较。
Microb Pathog. 2018 Apr;117:23-26. doi: 10.1016/j.micpath.2018.02.010. Epub 2018 Feb 8.
7
Impact of insufficient doses of medications on eradication: a retrospective observational study.药物剂量不足对根除的影响:一项回顾性观察研究。
Postgrad Med. 2022 Sep;134(7):668-674. doi: 10.1080/00325481.2022.2105094. Epub 2022 Jul 26.
8
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.泮托拉唑、铋剂、四环素和甲硝唑四联疗法作为幽门螺杆菌感染挽救治疗的疗效。
Aliment Pharmacol Ther. 2002 Aug;16(8):1457-60. doi: 10.1046/j.1365-2036.2002.01304.x.
9
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).一种新型短期四联疗法根除幽门螺杆菌的临床结局及影响因素:一项随机对照试验(MACLOR研究)
Arch Intern Med. 2002 Jan 28;162(2):153-60. doi: 10.1001/archinte.162.2.153.
10
Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.溃疡患者中四联疗法与双重疗法根除幽门螺杆菌的比较:一项随机前瞻性单中心研究的结果
Eur J Gastroenterol Hepatol. 1995 Dec;7(12):1189-94. doi: 10.1097/00042737-199512000-00011.

引用本文的文献

1
Retracted: Effects of Quadruple Therapy Combined with Probiotics on -Related Peptic Ulcer.撤回:四联疗法联合益生菌对 - 相关性消化性溃疡的影响
Comput Math Methods Med. 2023 Nov 29;2023:9795212. doi: 10.1155/2023/9795212. eCollection 2023.

本文引用的文献

1
[Helicobacter pylori and peptic ulcer].[幽门螺杆菌与消化性溃疡]
Nihon Shokakibyo Gakkai Zasshi. 2021;118(10):920-926. doi: 10.11405/nisshoshi.118.920.
2
Low Abundance in the Lower Gut Microbiota Is Associated With -Related Gastric Ulcer and Gastric Cancer.下消化道微生物群中低丰度与 - 相关胃溃疡和胃癌有关。 你提供的原文中“-Related”这里似乎有信息缺失,不太明确完整准确的意思。
Front Microbiol. 2021 Feb 26;12:631140. doi: 10.3389/fmicb.2021.631140. eCollection 2021.
3
Diagnostic Value of Serum Gastrin and Epidermal Growth Factor to the Gastric Ulcer Complicated with Upper Gastrointestinal Hemorrhage.血清胃泌素和表皮生长因子对胃溃疡合并上消化道出血的诊断价值
J Coll Physicians Surg Pak. 2020 Dec;30(12):1269-1272. doi: 10.29271/jcpsp.2020.12.1269.
4
Treatment of Helicobacter pylori infection: a clinical practice update.治疗幽门螺杆菌感染:临床实践更新。
Minerva Med. 2021 Apr;112(2):281-287. doi: 10.23736/S0026-4806.20.06810-X. Epub 2020 Jul 22.
5
Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for infection.铋剂四联疗法中阿莫西林或四环素作为一线治疗 感染。
Gut Microbes. 2020 Sep 2;11(5):1314-1323. doi: 10.1080/19490976.2020.1754118. Epub 2020 May 2.
6
Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial.埃索美拉唑-阿莫西林双联疗法治疗幽门螺杆菌感染的疗效:一项开放标签、随机试验。
Eur J Gastroenterol Hepatol. 2020 May;32(5):563-568. doi: 10.1097/MEG.0000000000001646.
7
Virulence Factors Exploiting Gastric Colonization and its Pathogenicity.利用胃定植和致病性的毒力因子。
Toxins (Basel). 2019 Nov 19;11(11):677. doi: 10.3390/toxins11110677.
8
Pathogenesis and clinical management of gastric infection.胃感染的发病机制和临床管理。
World J Gastroenterol. 2019 Oct 7;25(37):5578-5589. doi: 10.3748/wjg.v25.i37.5578.
9
Management of Antibiotic-Resistant Infection: Perspectives from Vietnam.抗生素耐药感染的管理:来自越南的观点。
Gut Liver. 2019 Sep 15;13(5):483-497. doi: 10.5009/gnl18137.
10
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.幽门螺杆菌根除治疗中挽救性铋剂四联疗法失败的危险因素。
J Gastroenterol Hepatol. 2019 Apr;34(4):666-672. doi: 10.1111/jgh.14625. Epub 2019 Feb 25.